1-Asadi A, Khavari Nejad R, Soltani N, Najafi F, Molaei Rad A. Physiological and antimicrobial characterizations of some cyanobacteria isolated from the rice fields in Iran. J Agri Technol 2011; 7(3): 649-663.
2-Katsanis G P, Sparqo J, Ferraro M J, Sutton l, Jakobi GA. Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended-spectrum beta-lactamases. Journal of clinical microbiology 1994; 32(3): 691-696.
3-Rapp RP, Urban C. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2012; 32(5): 399-407.
4-Vatopoulos A. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece--a review of the current evidence. Euro surveillance: bulletin Europeen sur les maladies transmissibles= European communicable disease bulletin 2008; 13(4): 1854-1861.
5-Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clinical Infectious Diseases 2001; 32(8): 1162-1171.
6-Fisher JF, Meroueh SO, Mobashery S. Bacterial resistance to β-lactam antibiotics: compelling opportunism, compelling opportunity. Chemical reviews 2005;105(2): 395-424.
7-Rothstein JD, Kuncl RW. β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 2005; 433(7021): 73-77.
8-Wilke MS, AL Lovering, NC Strynadka. β-Lactam antibiotic resistance: a current structural perspective. Current opinion in microbiology 2005; 8(5): 525-533.
9-Zhanel GG, Wiebe R, Dilay L, Thomson K, Rubinstien E. Comparative review of the carbapenems. Drugs 2007; 67(7): 1027-1052.
10-DePestel DD, Beninger MS, Danziger L, Laplante KL, May C, Luskin A, "et al". Cephalosporin use in treatment of patients with penicillin allergies. Journal of the American Pharmacists Association: JAPhA 2007; 48(4): 530-540.
11-Petri W. Penicillins, cephalosporins, and other β-lactam antibiotics. Goodman & Gilman’s, The Pharmacologic Basis of Therapeutics 2006; 1127-1154.
12-Cuzon G, Nass T , Nordmann p. KPC carbapenemases: what is at stake in clinical microbiology? Pathol Biol(Paris) 2010; 58(1): 39-45.
13-da Silva RM, Traebert J, Galato D. Klebsiella pneumoniae carbapenemase (KPC)producing klebsiella pneumoniae :a review of epidemiological and clinical aspects. Expert Opin Biol Ther 2012; 12(6): 663-671.
14- Benson AE. Microbiological Applications Lab Manual. 8 th ed. Newyork: McGraw−Hill; 2011.
15-CLSI. Performance standards for Antimicrobial Susceptibility Testing :Twentieth informao nal supplemented .CLSI document M100-S20.Wayne , PA: Clinical and Laboratory Standards Ins ute;2013
16-Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrobial Agents and chemotherapy 2010; 54(3): 969-976.
17- Mullis KB, Faloona FA. Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. Methods in Enzymology 1999; 155: 224-249.
18- Bartlett JM, Strling D. A short history of polymerase chain reaction. Methods Mol Biol 2003; 226: 3-6.
19-Sambrook J, Russel DW. Molecolar cloning a laboratory mannual. 3ed . New York: CSHL Press; 2001.
20-Rasheed JK, Biddle JW, Karen FA, Washer L, Chenowet C, Perrin J. Detection of the Klebsiella pneumoniae Carbapenemase Type 2 Carbapenem-Hydrolyzing Enzyme in Clinical Isolates of Citrobacter freundii and K. oxytoca Carrying a Common Plasmid. J OURNAL OF CLINICAL MICROBIOLOGY, 2008 June; 46(6): 2066–2069.
21-LIU L, Chen GQ. Susceptibility, Classification and Distribution of Extended-spectrum βLactamases Produced by Klebsiella pneumoniae in China [J]. Chinese Journal of Nosoconmiology 2005; 9.
22-Bush K, Jacoby GA. Updated functional classification of β-lactamases. Antimicrobial Agents and chemotherapy 2010; 54(3): 969-976.
23-Fazeli H, Akbari R, Moghim SH, Narimani T, Arabestani MR, Ghoddousi AR. Pattern of Antibiotic Resistance in Pesudomonas Aeruginosa Isolated from Intensive Care Unit, Isfahan, Iran. Journal of Isfahan Medical School 2013; (31): 232.
24-Wood ford N,Tiemo PM JR,Young K. Outbreak of Klebsiella pneumoniae Producing a New Carbapenem –Hydrolyzing ClassA beta-Lactamase,KPC -3,in a New York Medical Center. Antimicrob Agents Chemother 2004; 48(12): 4793-4799.
25- Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, "et al". Carbapenemase-producing Klebsiella pneumoniae in Brooklyn , NY :Molecular epidemiology and in vitro activity of polymyxin B and other agents . J Antimicrob Chemother 2005; 56(1):128-132.
26-Hashemizadeh FS, Zamanzad B, Jahandideh S, Ansari N, Gholipour A, Hashemizadeh FS, "et al". Identification of KPC-producing Klebsiella pneumoniae in clinical samples in Iran.
Yakhteh 2013; 15 (1) :105-114
27-Kim SY, Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea. Diagnostic microbiology and infectious disease 2013 Aug; 76(4): 486-490.
28-Chen S, Hu F, Xu X, Liu Y, Wu W, Zhu D. High Prevalence of KPC-2-Type Carbapenemase Coupled with CTX-M-Type Extended-Spectrum beta-lactamases in Carbapenem –Resistant Klebsiella pneumoniae in a Teaching Hospital in China. Antimicrob Agents Chemother 2011; 55(5): 2493-2494.
29-Geffena Y, Finkelstein R, Oren I, Shalaginov R, Tavleva I, Sprecher H. Changing epidemiology of carbapenem-resistant Enterobacteriace carriage during an outbreak of carbapenem-resistant Klebsiella pneumonia .J Hosp Infect 2010; 76(4): 355-356.
30-Kontopoulou K, Protonotariou E, Vasilakos K. Hospital outbreak caused by Klebsiella pnumoniae producing KPC-2 beta –lactamase resistant to colistin. J Hosp Infect 2010; 76(1): 70-73.